CDC updates flu recommendations

CDC issued updated recommendations for the use of antiviral medications to treat and prevent seasonal influenza and swine influenza A (H1N1) during the 2009-10 season. The agency continues to recommend treatment with Tamiflu oseltamivir from Roche (SIX:ROG; OTCQX:RHHBY) and Gilead Sciences Inc. (NASDAQ:GILD) and Relenza zanamivir from Biota Holdings Ltd. (ASX:BTA) and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) for persons with suspected or confirmed influenza requiring hospitalization or persons with suspected or confirmed influenza who are at higher risk for complications. Gilead was up $0.70 to $46.83 on Tuesday. Biota was up A$0.04 to A$2.12. ...